There are 2789 resources available
1289P - Intracranial response (ICR) following immunotherapy in non-small cell lung cancer (NSCLC) patients with untreated brain metastasis (BM)
Presenter: Birgitte Bjoernhart
Session: ePoster Display
1242P - Anlotinib with gefitinib as first-line therapy in advanced non-small cell lung cancer harboring EGFR mutations: A phase II study
Presenter: Yajun Ji
Session: ePoster Display
1127P - Cancer and Age Research Group (CARG) predicting chemotherapy toxicity in elderly patients with cancer
Presenter: Dalila Miraoui
Session: ePoster Display
1128P - Genotypic and phenotypic evaluation of the pharmacokinetics of irinotecan and its relationship with the occurrence of toxicity in the treatment of cancer
Presenter: Jeziel Basso
Session: ePoster Display
1130P - Anchored multiplex PCR-based targeted sequencing for the detection of fusion transcripts in FFPE samples of non-small cell lung cancer patients
Presenter: Audrey Vallée
Session: ePoster Display
1185P - Induction immunotherapy in resectable non-small cell lung cancer harboring driver mutations: A multi-center retrospective study
Presenter: Chao Zhang
Session: ePoster Display
1292P - Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
Presenter: Ryo Toyozawa
Session: ePoster Display
1134P - Personalized medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction
Presenter: Paweł Zawadzki
Session: ePoster Display
1135P - Impact of MCED screening interval on reduction in late-stage cancer diagnosis and mortality
Presenter: Peter Sasieni
Session: ePoster Display